Presentation is loading. Please wait.

Presentation is loading. Please wait.

Schematic representation of signaling by EBV EBNA-2.

Published byHandoko Suharto Gunawan Modified over 5 years ago

Similar presentations

Presentation on theme: "Schematic representation of signaling by EBV EBNA-2."— Presentation transcript:

1 Schematic representation of signaling by EBV EBNA-2.
Schematic representation of signaling by EBV EBNA-2. Targets for EBV EBNA-2 (center column) and biological effects (right column) are shown. c-fgr, feline Gardner-Rasheed sarcoma viral oncogene homolog; UCHL1, ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase); MAPK, mitogen-activated protein kinase; PI3K, phosphatidylinositol 3-kinase; JAK/STAT, Janus kinase/signal transducer and activator of transcription. Martyn K. White et al. Clin. Microbiol. Rev. 2014; doi: /CMR

Download ppt "Schematic representation of signaling by EBV EBNA-2."

Similar presentations

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non- small cell lung cancer: Focus on epidermal growth factor receptor.

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non- small cell lung cancer: Focus on epidermal growth factor receptor.
Advances in Molecular Biology of Lung Disease

Advances in Molecular Biology of Lung Disease
Relapsed/Refractory Multiple Myeloma: Defining Refractory Disease and Identifying Strategies to Overcome Resistance  David S. Siegel  Seminars in Hematology 

Relapsed/Refractory Multiple Myeloma: Defining Refractory Disease and Identifying Strategies to Overcome Resistance  David S. Siegel  Seminars in Hematology 
Figure 2 Inflammatory pathways affecting hepatic insulin resistance

Figure 2 Inflammatory pathways affecting hepatic insulin resistance
Figure 1 Pathogenic mechanisms and pathways in ADPKD

Figure 1 Pathogenic mechanisms and pathways in ADPKD
Potential pathways directly linking obesity with cancer.

Potential pathways directly linking obesity with cancer.
Figure 5 Defects in the JAK–STAT signalling pathway

Figure 5 Defects in the JAK–STAT signalling pathway
Figure 1 A schematic representation of the HER2 signalling pathway

Figure 1 A schematic representation of the HER2 signalling pathway
Figure 2 Oestrogen receptor signalling pathways

Figure 2 Oestrogen receptor signalling pathways
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Tammo Ostendorf, Peter Boor, Claudia R.C. van Roeyen, Jürgen Floege 

Tammo Ostendorf, Peter Boor, Claudia R.C. van Roeyen, Jürgen Floege 
Figure 1 Therapeutic targeting of the B-cell receptor (BCR)

Figure 1 Therapeutic targeting of the B-cell receptor (BCR)
Schematic view of Trk receptors signalling, showing the three major pathways involved in cell differentiation and survival. Schematic view of Trk receptors.

Schematic view of Trk receptors signalling, showing the three major pathways involved in cell differentiation and survival. Schematic view of Trk receptors.
Fig. 6. Pathway analysis of CMLD

Fig. 6. Pathway analysis of CMLD
The Genetic Landscape of Malignant Pleural Mesothelioma: Results from Massively Parallel Sequencing  Marieke Hylebos, MSc, Guy Van Camp, PhD, Jan P van.

The Genetic Landscape of Malignant Pleural Mesothelioma: Results from Massively Parallel Sequencing  Marieke Hylebos, MSc, Guy Van Camp, PhD, Jan P van.
Itraconazole tissue and fluid concentrations in humans as multiples of the maximal or simultaneously measured concentration in plasma (μg/ml) after systemic.

Itraconazole tissue and fluid concentrations in humans as multiples of the maximal or simultaneously measured concentration in plasma (μg/ml) after systemic.
Amino acid alignment of TprK showing six different sequences in the T

Amino acid alignment of TprK showing six different sequences in the T
Voriconazole tissue and fluid concentrations in humans as multiples of the maximal or simultaneously measured concentration in plasma (μg/ml) after systemic.

Voriconazole tissue and fluid concentrations in humans as multiples of the maximal or simultaneously measured concentration in plasma (μg/ml) after systemic.
The human norovirus genome.

The human norovirus genome.
EBV infection in healthy carriers.

EBV infection in healthy carriers.

Similar presentations

Ads by Google